The heparan sulfates (HS) are structurally the most complex but information rich biopolymers known. They are composed of polysaccharides containing regioselectively distributed carboxyl, sulfate ester, acetyl, amino, and N-sulfonyl groups with sequence- and domain-like arrangements. HS are found ubiquitously on cell surfaces and in extracellular matrices where they are covalently anchored via restricted protein cores. They modulate numerous development cell processes and the pathology of living organisms. HS concentration is extremely low on endothelial cell surfaces (1 pmol/cm2), therefore, they are difficult to isolate and evaluate. Furthermore, their sequence variability is extremely high and the sequence analysis is in its infancy. HS acts as a low affinity receptor which plays a central role in the reception and modulation of a wide range of effector proteins such as growth factors, morphogens, chemokines, enzymes, protease inhibitors.
Water soluble fragments of HS and heparin (HE) enzymatically released or synthetic sequences, analogs of heparinoids and heparanoids (HH) mimetics regioselectively modified oligo- and polysaccharides with HE/HS like functional groups, and nonsaccharide containing structures can modulate effector proteins and influence some of the development and pathological processes. Modulation effects are described for anticoagulant antiproliferative properties, for reducing platelet and plasma protein adhesion as well as inhibition or activating growth factors by the influence of HH mimetics. The advantage of defined high molecular weight substrates are discussed and compared to the low molecular weight mimetics. The potential of HH mimetics opens new approaches and strategies for therapeutic treatment.
Get full access to this article
View all access options for this article.
References
1.
1. Gallagher, J.T. (2001). Heparan Sulfate: Growth Control with a Restricted Sequence Menu , J. Clin. Invest., 108: 357-361 .
2.
2. Tumova, S., Woods, A. and Couchman, J.R. (2000). Heparan Sulfate Proteoglycans on the Cell Surface: Versatile Coordinators of Cellular Functions , Int. J. Biochem. Cell. Biol., 32: 269-288 .
3.
3. Sasisekharan, R. and Venkataraman, G. (2000). Heparin and Heparan sulfate: Biosynthesis, Structure and Function , Curr. Opin. Chem. Biol., 4: 626-631 .
4.
4. Venkataraman, G., Shriver, Z., Davis, J.C. and Sasisekharan, R. (1999). Fibroblast Growth Factors 1 and 2 are Distinct in Oligomerization in the Presence of Heparin-like Glycosaminoglycans , In: Proc. Natl. Acad. Sci. USA, 96: 1892-1897 .
5.
5. Rong, J., Nordling, K., Bjork, I. and Lindahl, U. (1999). A Novel Strategy to Generate Biologically Active Neo-glycosaminoglycan Conjugates , Glycobiology, 9: 1331-1336 .
6.
6. Ornitz, D.M., Herr, A.B., Nilsson, M., Westman, J., Svahn, C.-M. and Waksman, G. (1995). FGF Binding and FGF Receptor Activation by Synthetic Heparan-derived Di- and Trisaccharides , Science, 268: 432-436 .
7.
7. Vlodavsky, I. and Friedmann, Y. (2001). Molecular Properties and Involvement of Heparanase in Cancer Metastasis and Angiogenesis , J. Clin. Invest., 108: 341-347 .
8.
9. Van Boeckel, C.A.A. and Petitou, M. (1993). Die charakteristische AT-III-Bindungsregion in Heparin: eine Leitstruktur für neue synthetische Antithrombotica , Angew. Chem., 105: 1741-1761 .
9.
10. Petitou, M., Hérault, J.-P., Bernat, A., Driguez, P.-A., Duchaussoy, P., Lormeau, J.-C. and Herbert, J.-M. (1999). Synthesis of thrombin-inhibiting Heparin Mimetics without Side Effects , Letters to Nature, 398: 417-422 .
10.
11. Petitou, M., Duchaussoy, P., Herbert, J.-M., Duc, G., El Hajji, M., Branellec, J.F., Donat, F., Necciari, J., Cariou, R., Bouthier, J. and Garrigou, E. (2002). The Synthetic Pentasaccharide Fondaparinux: First in the Class of Antithrombotic Agents that Selectively Inhibit Coagulation Factor Xa , Semin. Thromb. Hemost., 28: 393-402 .
11.
12. Wessel, H.P. (1997). Heparinoid Mimetics. In: Driguez, H. and Thiem, J. (Eds.), Topics in Current Chemistry, Vol. 187, pp. 216-237, Springer Verlag, Berlin .
12.
13. Conrad, H.E. (1998). Heparin-Binding Proteins, Academic Press, San Diego, California .
13.
14. Gallagher, J.T. (1998). The Interaction and Regulation of Basic and Acidic Fibroblast Growth Factors by Heparan Sulfate , Trends Glycosci. Glycobiol., 10: 137-144 .
14.
15. Baumann, H., Huppertz, B., Sharon, R., Tessler, S. and Neufeld, G. (1999). The Influence of Functional Groups on Semisynthetic Heparin Like Molecules on Binding to Vascular Endothelial Growth Factor (VEGF). In: Ottenbrite, R., Chiellini, E., Cohn, D., Miglaresi, C. and Sunamoto, I. (Eds.), Frontiers in Biomedical Polymer Applications, Vol. 2, pp. 115-129, Technomic, Lancaster .
15.
16. Baumann, H. (2002). The Influence of Synthetic Heparin and Heparan Mimetics or Analoga for Drug Design , Preprints ACS Meeting Boston, Poly 712; 224 .
16.
17. Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H. and Neufeld, G. (1998). Neuropilin-1 is a Placenta Growth Factor-2 Receptor , J. Biol. Chem., 273: 22272-22278 .
17.
18. Lyon, M. and Gallagher, J.T. (1998). Bio-specific Sequences and Domains in Heparan Sulphate and the Regulation of Cell Growth and Adhesion , Matrix Biol., 17: 485-493 .
18.
19. Pye, D. A., Vives, R.R., Hyde, P. and Gallagher, J.T. (2000). Regulation of FGF-1 Mitogenic Activity by Heparan Sulfate Oligosaccharides is Dependent on Specific Structural Features: Differential Requirements for the Modulation of FGF-1 and FGF-2 , Glycobiology, 10: 1183-1192 .
19.
20. Pye, D.A. and Gallagher, J.T. (1999). Monomer Complexes of Basic Fibroblast Growth Factor and Heparan Sulfate Oligosaccharides are the Minimal Functional Unit for Cell Activation , J. Biol. Chem., 274: 13456-13461 .
20.
21. Guimond, S.E., Maccarana, M., Olwin, B.B., Lindahl, U. and Rapraeger, A.C. (1993). Activating and Inhibitory Heparin Sequences for FGF-2 (Basic FGF). Distinct Requirements for FGF-1, FGF-2 and FGF-4 . J. Biol. Chem., 268: 23906-23914 .
21.
22. Guimond, S.E. and Turnbull, J.E. (1999). Fibroblast Growth Factor Receptor Signaling is Dictated by Specific Heparan Sulfate Saccharides , Curr. Biol., 9: 1343-1346 .
22.
23. Ishihara, M., Shaklee, P.N., Yang, Z., Liang, W., Wei, Z., Stack, R.J. and Holme, K. (1994). Structural Features in Heparin which Modulate Specific Biological Activities Mediated by Basic Fibroblast Growth Factor , Glycobiology, 4: 451-458 .
23.
24. Baumann, H. (2001). The Role of Regioselectively Sulphated and Acetylated Polysaccharide Coatings of Biomaterials for Reducing Platelet and Plasma Protein Adhesion , Sem. Thromb. Hemost., 27: 445-463 .
24.
25. Kariya, Y., Kyogashima, M., Suzuki, K., Isomura, T., Sakamoto, T., Horie, K., Ishihara, M., Takano, R., Kamei, K. and Hara, S. (2000). Preparation of Completely 6-O-desulfated Heparin and its Ability to Enhance Activity of Basic Fibroblast Growth Factor , J. Biol. Chem., 275: 25949-25958 .
25.
26. Maccarana, M., Casu, B. and Lindahl, U. (1993). Minimal Sequence in Heparin/Heparan Sulfate Required for Binding of Basic Fibroblast Growth Factor , J. Biol. Chem., 268: 23898-23905 .
26.
27. Parish, C.R., Freeman, C., Brown, K.J. and Francis, D.J. and Cowden, W.B. (1999). Identification of Sulfated Oligosaccharide-based Inhibitors of Tumor Growth and Metastasis Using Novel in vitro Assays for Angiogenesis and Heparanase Activity , Cancer Res., 59: 3433-3441 .
27.
28. Perrimon, N. and Bernfield, M. (2000). Specificities of Heparan Sulphate Proteoglycans in Developmental Processes , Nature, 404: 725-728 .
30. Baumann, H. (2002). Concepts for Synthesis of Bioactive Regioselectively Sulfated and Acetylated Derivatives of Cellulose, Chitosan, Heparin and Heparansulfate with Highest Possible Completeness: Defined Polysaccharides for Drug Design. Part I and Part II , Bioac. Comp. Polym., in preparation.
30.
31. Stringer, S.E. and Gallagher, J.T. (1997). Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate , J. Biol. Chem., 272: 20508-20514 .
31.
32. Brown, K.J. and Parish, C.R. (1994). Histidine-rich Glycoprotein and Platelet Factor 4 Mask Heparan Sulfate Proteoglycans Recognized by Acidic and Basic Fibroblast Growth Factor , Biochemistry, 33: 13918-13927 .
32.
33. Baumann, H., Scheen, H., Huppertz, B. and Keller, R. (1998). Novel Regio- and Stereoselective O-6-desulfation of the Glucosamine Moiety of Heparin with N-Methylpyrrolidinone-Water or N,N-Dimethylformamide-Water Mixtures , Carbohydr. Res., 308: 381-388 .
33.
34. Baumann, H., Richter, A., Klemm, D. and Faust, V. (2000). Concepts for Preparation of Novel Regioselective Modified Cellulose Derivatives Sulphated, Aminated for Hemocompatible Ultrathin Coatings on Biomaterials , Macromol. Chem. Phys., 201: 1950-1962 .
34.
35. Baumann, H. and Faust, V. (2001). Concepts for Improved Regioselective Placement of O-Sulfo, N-Sulpho, N-Acetyl, and N-Carboxymethyl Groups in Chitosan Derivatives , Carbohydr. Res., 331: 43-57 .
35.
36. Liu, C. and Baumann, H. (2002). Exclusive and Complete Introduction of Amino Groups and their N-Sulfo and N-Carboxymethyl Groups into the 6-Position of Cellulose Without the Use of Protecting Groups . Carbohydr. Res., 337: 1297-1307 .
36.
37. Keiser, N., Venkataraman, G., Shriver, Z. and Sasisekharan, R. (2001). Direct Isolation and Sequencing of Specific Protein-binding Glycosaminoglycans , Nature Medicine, 7: 123-128 .
39. Mulloy, B., Forster, M.J., Jones, C. and Davies, D.B. (1993). N.M.R. and Molecular-modelling Studies of the Solution Conformation of Heparin , Biochem. J., 293: 849-858 .
39.
40. Mulloy, B. and Forster, M.J. (2000). Conformation and Dynamics of Heparin and Heparan Sulfate , Glycobiology, 10: 1147-1156 .
40.
41. Jin, L., Abrahams, J.P., Skinner, R., Petitou, M., Pike, R.N. and Carrel, R.W. (1997). The Anticoagulant Activation of Antithrombin by Heparin , In: Proc. Natl. Acad. Sci. USA, 94: 14683-14688 .
41.
42. Turnbull, J.E., Hopwood, J.J. and Gallagher, J.T. (1999). A Strategy for Rapid Sequencing of Heparan Sulfate and Heparin Saccharides , In: Proc. Natl. Acad. Sci. USA, 96: 2698-2703 .
42.
43. Vives, R.R., Pye, D.A., Salmivirta, M., Hopwood, J.J., Lindahl, U. and Gallagher, J.T. (1999). Sequence Analysis of Heparan Sulphate and Heparin Oligosaccharides , Biochem. J., 339: 767-773 .
43.
44. Rhomberg, A.J., Shriver, Z., Biemann, K. and Sasisekharan, R. (1998). Mass Spectrometric Evidence for the Enzymatic Mechanism of the Depolymerization of Heparin-like Glycosaminoglycans by Heparinase II , In: Proc. Natl. Acad. Sci. USA, 95: 12232-12237 .
44.
45. Rosenberg, R.D. and Lam, L. (1979). Correlation Between Structure and Function of Heparin , In: Proc. Natl. Acad. Sci. USA, 76: 1218-1222 .
45.
46. Lindahl, U., Thunberg, L., Backstrom, G., Riesenfeld, J., Nordling, K. and Bjork, J. (1984). Extension and Structural Variability of the Antithrombinbinding Sequence in Heparin , J. Biol. Chem., 259: 12368-12376 .
46.
47. Lam, L.H., Silbert, J.E. and Rosenberg, R.D. (1976). The Separation of Active and Inactive Forms of Heparin , Biochem. Biophys. Res. Commun., 69: 570-577 .
47.
48. De Boer, H.C., de Groot, P.G., Bouma, B.N. and Preissner, K.T. (1993). Ternary Vitronectin-thrombin-antithrombin III Complexes in Human Plasma, Detection and Mode of Association , J. Biol. Chem., 268: 1279-1283 .
48.
49. Prestrelski, S.J., Fox, G.M. and Arakawa, T. (1992). Binding of Heparin to Basic Fibroblast Growth Factor Induces a Conformational change , Arch. Biochem. Biophys., 293: 314-319 .
49.
50. Davis, J.C., Venkataraman, G., Shriver, Z., Raj, P.A. and Sasisekharan, R. (1999). Oligomeric Self-association of Basic Fibroblast Growth Factor in the Absence of Heparin-like Glycosaminoglycans , Biochem. J., 341: 613-620 .
50.
51. Kan, M., Wang, F., Xu, J., Crabb, J.W., Hou, J. and McKeehan, W.L. (1993). An Essential Heparin-binding Domain in the Fibroblast Growth Factor Receptor Kinase , Science, 259: 1918-1921 .
51.
52. Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K. and Lindahl, U. (1996). Domain Structure of Heparan Sulfates from Bovine Organs , J. Biol. Chem., 271: 17804-17810 .
